202 related articles for article (PubMed ID: 30537312)
1. Patterns of infiltration and local recurrences of various types of cutaneous sarcomas following three-dimensional histology.
Welsch K; Breuninger H; Metzler G; Sickinger F; Eberle FC; Häfner HM; Schnabl SM
J Dtsch Dermatol Ges; 2018 Dec; 16(12):1434-1442. PubMed ID: 30537312
[TBL] [Abstract][Full Text] [Related]
2. A 10-year analysis of cutaneous mesenchymal tumors (sarcomas and related entities) in a skin cancer center.
Wollina U; Koch A; Hansel G; Schönlebe J; Kittner T; Pabst F; Haroske G; Nowak A
Int J Dermatol; 2013 Oct; 52(10):1189-97. PubMed ID: 23829640
[TBL] [Abstract][Full Text] [Related]
3. 3D-Histological evaluation of surgery in dermatofibrosarcoma protuberans and malignant fibrous histiocytoma: differences in growth patterns and outcome.
Häfner HM; Moehrle M; Eder S; Trilling B; Röcken M; Breuninger H
Eur J Surg Oncol; 2008 Jun; 34(6):680-6. PubMed ID: 17716851
[TBL] [Abstract][Full Text] [Related]
4. Sarcomas arising in dermatofibrosarcoma protuberans: a reappraisal of biologic behavior in eighteen cases treated by wide local excision with extended clinical follow up.
Goldblum JR; Reith JD; Weiss SW
Am J Surg Pathol; 2000 Aug; 24(8):1125-30. PubMed ID: 10935653
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Mesenchymal Sarcomas.
Walocko F; Christensen RE; Worley B; Alam M
Dermatol Clin; 2023 Jan; 41(1):133-140. PubMed ID: 36410974
[TBL] [Abstract][Full Text] [Related]
6. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous mesenchymal tumors treated with Mohs micrographic surgery: a comprehensive review.
Rosenfeld DJ; Cappel MA; Tolkachjov SN
Int J Dermatol; 2021 Nov; 60(11):1334-1342. PubMed ID: 33715156
[TBL] [Abstract][Full Text] [Related]
8. Increase of atypical fibroxanthoma and pleomorphic dermal sarcoma: a retrospective analysis of four German skin cancer centers.
Kuntz T; Siebdrath J; Hofmann SC; Baltaci M; Schaller J; Hellmich M; von Goltzheim LS; Assaf C; Oellig F; Michalowitz AL; Helbig D; Kreuter A
J Dtsch Dermatol Ges; 2022 Dec; 20(12):1581-1588. PubMed ID: 36442137
[TBL] [Abstract][Full Text] [Related]
9. Atypical fibroxanthoma-a diagnosis of exclusion!
Tchernev G; Tronnier M; Ananiev J; Taneva T; Patterson JW; Gulubova M; Trafeli JP; Gegova A; Harrell M; Guarneri C; Wollina U; Cardoso JC; Kanazawa N; Zisova L; Forsea AM; Zouboulis CC
Wien Med Wochenschr; 2013 Aug; 163(15-16):380-6. PubMed ID: 23319144
[TBL] [Abstract][Full Text] [Related]
10. Micrographic surgery ('slow Mohs') in cutaneous sarcomas.
Hafner J; Schütz K; Morgenthaler W; Steiger E; Meyer V; Burg G
Dermatology; 1999; 198(1):37-43. PubMed ID: 10026400
[TBL] [Abstract][Full Text] [Related]
11. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.
DuBay D; Cimmino V; Lowe L; Johnson TM; Sondak VK
Cancer; 2004 Mar; 100(5):1008-16. PubMed ID: 14983497
[TBL] [Abstract][Full Text] [Related]
12. Malignant fibrous tumors.
Stadler FJ; Scott GA; Brown MD
Semin Cutan Med Surg; 1998 Jun; 17(2):141-52. PubMed ID: 9669607
[TBL] [Abstract][Full Text] [Related]
13. Dermatofibrosarcoma protuberans in children and adolescents: Clinical presentation, histology, treatment, and review of the literature.
Tsai YJ; Lin PY; Chew KY; Chiang YC
J Plast Reconstr Aesthet Surg; 2014 Sep; 67(9):1222-9. PubMed ID: 24973861
[TBL] [Abstract][Full Text] [Related]
14. Soft tissue sarcomas in dermatology.
Fish FS
Dermatol Surg; 1996 Mar; 22(3):268-73. PubMed ID: 8599739
[TBL] [Abstract][Full Text] [Related]
15. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
16. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.
Snow SN; Gordon EM; Larson PO; Bagheri MM; Bentz ML; Sable DB
Cancer; 2004 Jul; 101(1):28-38. PubMed ID: 15221986
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans: a rare entity and review of the literature.
Stamatakos M; Fyllos A; Siafogianni A; Ntzeros K; Tasiopoulou G; Rozis M; Kontzoglou K
J BUON; 2014; 19(1):34-41. PubMed ID: 24659640
[TBL] [Abstract][Full Text] [Related]
18. A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.
Harati K; Lange K; Goertz O; Lahmer A; Kapalschinski N; Stricker I; Lehnhardt M; Daigeler A
World J Surg Oncol; 2017 Jan; 15(1):5. PubMed ID: 28056985
[TBL] [Abstract][Full Text] [Related]
19. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.
Gloster HM; Harris KR; Roenigk RK
J Am Acad Dermatol; 1996 Jul; 35(1):82-7. PubMed ID: 8682970
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous sarcomas.
Kohlmeyer J; Steimle-Grauer SA; Hein R
J Dtsch Dermatol Ges; 2017 Jun; 15(6):630-648. PubMed ID: 28591457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
